RTW INVESTMENTS, LP

Q1 2021 13F-HR Holdings

Location
New York, NY
Holdings as of
3/31/2021
Date filed
5/14/2021
Form type
13F-HR
Num holdings
111
Total value ($000)
$6,405,753
Net value change ($000)
+445,489 (7.5%)
New positions
17
Sold out positions
8
Turnover %
14.5%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/16/2021 Next filing: 8/13/2021 SEC filing

Snapshot: Change Analysis

Compared to Q4 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
SPY 375,029 NEW
QUIDEL CORP /DE/ 112,391 NEW
VCEL 111,448 79.9%
DermTech, Inc. 64,736 69.1%
iTeos Therapeutics, Inc. 58,457 162.5%
ESTA 57,724 66.1%
Prometheus Biosciences, Inc. 51,727 NEW
ILMN 51,242 38.3%
IMCR 50,142 NEW
GENETRON HLDGS LTD 39,018 NEW
Top Reduces (Value $000, Stocks/ETFs)
IMVT -248,724 -70.9%
RCKT -238,295 -25.5%
KRRO -86,792 -100.0%
STOK -77,952 -35.5%
ARVN -44,842 -29.5%
AXSM -44,726 -32.8%
FIVE PRIME THERAPEUTICS, INC. -42,794 -100.0%
LONA -40,092 -45.1%
KURA -24,994 -45.0%
LUNG -23,171 -31.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type